mRNA vaccines have changed the way we fight infectious diseases. Introducing Pfizer’s phase 3 research study for an investigational flu vaccine using mRNA technology. Research is ongoing to evaluate an investigational mRNA flu vaccine.
By participating in this study, you can help us learn if this investigational vaccine is safe and can help the body produce antibodies which may help fight off the flu. When you participate in a study, you’re helping to represent both your community and all people who are affected by the flu and other infectious diseases. Your participation could make a difference. This research study is enrolling people who
You may qualify if you:
Qualified participates may receive:
Contact:
IMA Clinical Research -San Antonio
Formerly Diagnostics Research Group
4410 Medical Drive, Suite 360
San Antonio, Texas 78229
210-692-7157